Rare factor deficiencies

Current Opinion in Hematology

Volumn 19, Issue 5, 2012, Pages 380-384

  Hsieh, Loan ^a,b   Nugent, Diane ^a,b  

^a Children's Hospital   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

combined factor deficiencies; congenital factor deficiencies; rare factor deficiencies

Indexed keywords

BLOOD CLOTTING FACTOR;

BLEEDING DISORDER; BLOOD CLOTTING FACTOR DEFICIENCY; EUROPE; GENE SEQUENCE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INCIDENCE; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; RARE DISEASE; REGISTER; REVIEW; UNITED STATES;

BLOOD COAGULATION FACTORS; COAGULATION PROTEIN DISORDERS; HUMANS; RARE DISEASES;

EID: 84865425347     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e328356edd5     Document Type: Review

References (28)

1. Franchini M, Lippi G. Fibrinogen replacement therapy: a critical review of the literature. Blood Transfus 2012; 10:23-27.
2. Peyvandi F. Results of an international, multicentre pharmacokinetic trial in congenital fibrinogen deficiency. Thromb Res 2009; 124 (Suppl 2):S9-S11.
3. Manco-Johnson MJ, Dimichele D, Castaman G, et al. Fibrinogen Concentrate Study Group. Pharmacokinetics and safety of fibrinogen concentrate; J Thromb Haemost; 2009; 7:2064-2069.
4. Bornikova L, Peyvandi F, Allen G, et al. Fibrinogen replacement therapy for congenital fibrinogen deficiency. J Thromb Haemost 2011; 9:1687-1704.
5. de Moerloose P, Boehlen F, Neerman-Arbez M. Fibrinogen and the risk of thrombosis. Semin Thromb Hemost 2010; 36:7-17.
6. Lippi G, Favaloro EJ, Montagnana M, et al. Inherited and acquired factor V deficiency. Blood Coagul Fibrinolysis 2011; 22:160-166.
7. Asselta R, Peyvandi F. Factor V deficiency. Semin Thromb Hemost 2009; 35:382-389.
8. Cutler JA, Patel R, Rangarajan S, et al. Molecular characterization of 11 novel mutations in patients with heterozygous and homozygous FV deficiency. Haemophilia 2010; 16:937-942.
9. Simpson ML, Goldenberg NA, Jacobson LJ, et al. Simultaneous thrombin and plasmin generation capacities in normal and abnormal states of coagulation and fibrinolysis in children and adults. Thromb Res 2011; 127:317-323.
10. Chitlur M. Challenges in the laboratory analyses of bleeding disorders; Thromb Res; 2012; 130:1-6.
11. van Geffen M, van Heerde WL. Global haemostasis assays, from bench to bedside. Thromb Res 2012; 129:681-687.
12. Jouannelle C, Giansily-Blaizot M, Monpous F, et al. Spontaneous umbilical cord hematoma and congenital factor VII deficiency. Haemophilia 2012; 18:e24-e25.
13. Tran HT, Tjønnefjord GE, Pauss A, Holme PA. rVIIa administered by continuous infusion during surgery in patients with severe congenital FVII deficiency. Haemophilia 2011; 17:764-770.
14. Todd T, Perry DJ. A review of long-term prophylaxis in the rare inherited coagulation factor deficiencies. Haemophilia 2010; 16:569-583.
15. Franchini M, Lippi G. Recombinant activated factor VII: mechanisms of action and current indications. Semin thromb Hemost 2010; 36:485-492.
16. Girolami A, Vettore S, Ruzzon E, et al. Rare and unusual bleeding manifestations in congenital bleeding disorders: an annotated review. Clin Appl Thromb Hemost 2012; 18:121-127.
17. Ichinose A. Factor XIII is a key molecule at the intersection of coagulation and fibrinolysis as well as inflammation and infection control. Int J Hematol 2012; 95:362-370.
18. Muszbek L, Bagoly Z, Cairo A, et al. Novel aspects of factor XIII deficiency. Curr Opin Hematol 2011; 18:366-372.
19. Ivaskevicius V, Biswas A, Bevans C, et al. Identification of eight novel coagulation factor XIII subunit A mutations: implied consequences for structure and function. Haematologica 2010; 95:956-962.
20. Biswas A, Ivaskevicius V, Seitz R, et al. An update of the mutation profile of Factor 13A and B genes. Blood Rev 2011; 25:193-204.
21. Lusher J, Pipe SW, Alexander S, et al. Prophylactic therapy with Fibrogammin P is associated with decreased incidence of bleeding episodes: a retrospective study. Heamophilia 2010; 16:316-321.
22. Kohler HP, Ichinose A, Seitz R, et al. Diagnosis and classification of factor XIII deficiencies. J Throm Haemost 2011; 9:1404-1406.
23. Lawrie AS, Green L, Mackie J, et al. Factor XIII-an under diagnosed deficiency: are we using the right assays? J Thromb Haemost 2010; 8:2478-2482.
24. Inbal A, Oldenburg J, Carcao M, et al. Recombinant factor XIII, safe and novel treatment for congenital factor XIII deficiency. Blood 2012; 119:5111-5117.
25. Asatiani E, Kessler CM. Directors of the Comprehensive Hemophilia Treatment Centers in Region III; multiple congenital coagulopathies co-expressed with Von Willebrand's disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature. Haemophilia 2007; 13:685-696. (Pubitemid 350018257)
26. Zheng C, Liu HH, Yuan S, Zhou J, Zhang B; Molecular basis of LMAN1 in coordinating LMAN1-MCFD2 cargo receptor formation and ER-to-Golgi transport of FV/FVIII. Blood 2010; 116:5698-5706.
27. Spreafico M, Peyvandi F. Combined factor V and factor VIII deficiency. Semin Thromb Hemost 2009; 35:390-399.
28. Napolitano M, Mariani G, Lapecorella M. Hereditary combined deficiency of the vitamin K-dependent clotting factors. Orphanet J Rare Dis 2010; 14:21.